A contemporary look at allergic conjunctivitis.
Allergic conjunctivitis
Allergic conjunctivitis diagnosis
Allergic conjunctivitis treatment algorithm
Allergic eye disease
Interprofessional management
Ocular allergy
Journal
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
ISSN: 1710-1484
Titre abrégé: Allergy Asthma Clin Immunol
Pays: England
ID NLM: 101244313
Informations de publication
Date de publication:
2020
2020
Historique:
received:
14
08
2019
accepted:
09
01
2020
entrez:
30
1
2020
pubmed:
30
1
2020
medline:
30
1
2020
Statut:
epublish
Résumé
Allergic eye disease is common, yet often overlooked in North America. In the U.S., up to 40% of the population is deemed to be affected and this number is growing. Symptoms and signs of ocular allergy can lead to decreased productivity and negatively impact quality of life (QoL). Various treatment options exist to achieve symptom control. For allergic conjunctivitis, ophthalmic agents include antihistamines, mast cell stabilizers, dual-activity agents, nonsteroidal anti-inflammatory drugs (NSAIDs), steroids and some off-label treatments. Immunotherapy is recommended as a therapeutic option. This review provides a summary of the forms of ocular allergies, with a focus on symptoms and signs, impact on QoL, physical examination, diagnosis and therapeutic options of allergic conjunctivitis. Through multidisciplinary collaborations, a simplified algorithm for the treatment of allergic conjunctivitis is proposed for Canadian clinical practice.
Identifiants
pubmed: 31993069
doi: 10.1186/s13223-020-0403-9
pii: 403
pmc: PMC6975089
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
5Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Competing interestsCLP has received honoraria from Alcon, B+L, Innova Medical, Novartis, Shire for speaking and/or participation on advisory boards. HK has received honoraria from Astrazeneca, CSL Behring, Shire, Novartis, Pediapharm, Aralez, Mylan, Sanofi, Pfizer for speaking and/or participation on advisory boards. PD and AH have not received any pharmaceutical grants or payments. The authors declare no conflicts of interest in this work.
Références
JAMA Intern Med. 2015 Mar;175(3):401-7
pubmed: 25621434
BMJ Case Rep. 2010 Oct 28;2010:null
pubmed: 22791726
Ann Allergy Asthma Immunol. 2008 Mar;100(3 Suppl 3):S1-148
pubmed: 18431959
Allergy. 2017 Jan;72(1):43-54
pubmed: 27430124
Curr Med Res Opin. 2003;19(4):313-20
pubmed: 12841924
Ann Allergy Asthma Immunol. 2003 Aug;91(2):160-7
pubmed: 12952110
Clin Ther. 2003 Jul;25(7):2070-84
pubmed: 12946551
Surv Ophthalmol. 1993 Jul-Aug;38 Suppl:141-8
pubmed: 8236005
JAMA Ophthalmol. 2016 Apr;134(4):461-3
pubmed: 26795360
Eur J Ophthalmol. 2010 Mar-Apr;20(2):257-64
pubmed: 20037906
Ophthalmol Clin North Am. 2005 Dec;18(4):485-92, v
pubmed: 16314214
Clin Exp Allergy. 1994 Sep;24(9):884-7
pubmed: 7812890
Ophthalmology. 2019 Jan;126(1):P94-P169
pubmed: 30366797
Clin Ther. 2002 Oct;24(10):1561-75
pubmed: 12462286
J Dermatolog Treat. 2016 Oct;27(5):425-6
pubmed: 26822912
J Allergy Clin Immunol. 2000 Dec;106(6):1019-32
pubmed: 11112882
Curr Allergy Asthma Rep. 2010 Mar;10(2):122-34
pubmed: 20425504
Allergy Asthma Proc. 2014 May-Jun;35(3):211-8
pubmed: 24801463
Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001936
pubmed: 17253469
Allergy. 2018 Apr;73(4):765-798
pubmed: 28940458
Pediatr Allergy Immunol. 2006 Nov;17(7):524-6
pubmed: 17014628
Clin Ther. 2009 Sep;31(9):1908-21
pubmed: 19843481
Surv Ophthalmol. 2019 May - Jun;64(3):289-311
pubmed: 30550738
Inflamm Allergy Drug Targets. 2014;13(5):289-98
pubmed: 25373600
Allergy Asthma Proc. 2009 Jul-Aug;30(4):406-12
pubmed: 19467175
Clin Ther. 2003 Oct;25(10):2539-52
pubmed: 14667955
Allergy Asthma Proc. 2007 Jul-Aug;28(4):393-7
pubmed: 17883905
BMC Psychiatry. 2017 Mar 31;17(1):120
pubmed: 28359274
Dermatol Clin. 1992 Jul;10(3):505-12
pubmed: 1617809
J Allergy Clin Immunol. 2010 Oct;126(4):778-783.e6
pubmed: 20920769
Ital J Pediatr. 2013 Mar 14;39:18
pubmed: 23497516
Curr Opin Allergy Clin Immunol. 2011 Oct;11(5):471-6
pubmed: 21785348
Br J Ophthalmol. 2003 Oct;87(10):1206-11
pubmed: 14507747
Allergy Asthma Proc. 2000 Jul-Aug;21(4):235-9
pubmed: 10951891
Curr Opin Allergy Clin Immunol. 2007 Oct;7(5):429-35
pubmed: 17873584
Int Forum Allergy Rhinol. 2018 Nov;8(11):1253-1259
pubmed: 29782067
J Allergy Clin Immunol. 2011 Jan;127(1 Suppl):S1-55
pubmed: 21122901
Expert Rev Clin Immunol. 2010 Jan;6(1):101-9
pubmed: 20161677
Clin Ophthalmol. 2012;6:1731-8
pubmed: 23152650
Curr Opin Allergy Clin Immunol. 2008 Oct;8(5):445-9
pubmed: 18769199
Ophthalmic Epidemiol. 2004 Feb;11(1):17-33
pubmed: 14977494
Br J Dermatol. 2018 May;178(5):1083-1101
pubmed: 29193016
Ann Allergy Asthma Immunol. 2010 Nov;105(5):399-400
pubmed: 21055668
N Engl J Med. 2016 Dec 15;375(24):2335-2348
pubmed: 27690741
Allergy Asthma Clin Immunol. 2019 Oct 1;15:61
pubmed: 31582993
Cochrane Database Syst Rev. 2015 Jun 01;(6):CD009566
pubmed: 26028608
Otolaryngol Head Neck Surg. 2009 May;140(5):615-21
pubmed: 19393398
Clin Exp Allergy. 2011 Sep;41(9):1263-72
pubmed: 21848759
Ann Allergy Asthma Immunol. 2012 Apr;108(4):223.e1-15
pubmed: 22469456
J AAPOS. 2013 Jun;17(3):305-6
pubmed: 23607979
J Investig Allergol Clin Immunol. 2015;25(2):94-106
pubmed: 25997302
JAMA. 2001 Dec 19;286(23):2956-67
pubmed: 11743836
Pharmacoeconomics. 2004;22(6):345-61
pubmed: 15099121
Int J Pharm. 2016 Sep 10;511(1):73-78
pubmed: 27374205
Asian Pac J Allergy Immunol. 2018 Dec;36(4):217-221
pubmed: 29549698
Am J Ophthalmol. 2010 Jul;150(1):122-127.e5
pubmed: 20488431
J Allergy Clin Immunol. 1998 Aug;102(2):251-5
pubmed: 9723669
Allergy Asthma Proc. 2013 Sep-Oct;34(5):408-20
pubmed: 23998237
Osteoporos Int. 2018 Oct;29(10):2163-2170
pubmed: 30046925
Ophthalmology. 2013 Nov;120(11):2197-203
pubmed: 23743438
Mt Sinai J Med. 2011 Sep-Oct;78(5):740-58
pubmed: 21913203
Eye Contact Lens. 2004 Jan;30(1):10-3
pubmed: 14722462
Am J Rhinol Allergy. 2013 Jul-Aug;27(4):304-8
pubmed: 23636036
Ocul Immunol Inflamm. 2017 Oct;25(5):663-677
pubmed: 27192186
Expert Opin Pharmacother. 2013 Dec;14(18):2553-69
pubmed: 24191914
Respir Med. 2015 Aug;109(8):982-90
pubmed: 26153339
Allergy Asthma Clin Immunol. 2011 Nov 10;7 Suppl 1:S3
pubmed: 22166009
Recent Pat Biomed Eng. 2012 Apr 1;5(1):83-101
pubmed: 25414810
Laryngoscope. 2014 Mar;124(3):616-27
pubmed: 23832632
Curr Opin Allergy Clin Immunol. 2018 Oct;18(5):398-403
pubmed: 30015640
Curr Opin Allergy Clin Immunol. 2016 Oct;16(5):505-10
pubmed: 27490123
Allergy. 2019 Sep;74(9):1611-1630
pubmed: 30887530
Arch Ophthalmol. 1990 Apr;108(4):520-4
pubmed: 2322153
J Med Econ. 2011;14(3):305-14
pubmed: 21488807
J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):779-789.e6
pubmed: 27914815
Allergy Asthma Proc. 2009 Mar-Apr;30(2):128-38
pubmed: 19463203
Lancet. 2017 Jun 10;389(10086):2287-2303
pubmed: 28478972
Exp Appl Acarol. 2011 Dec;55(4):339-47
pubmed: 21751035
Prog Retin Eye Res. 2010 Jul;29(4):312-34
pubmed: 20302969
Ann Allergy Asthma Immunol. 2015 Sep;115(3):229-33
pubmed: 26254972
J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1778-1780.e1
pubmed: 29432961
Ann Allergy Asthma Immunol. 2013 Dec;111(6):465-507
pubmed: 24267359
Ophthalmology. 2001 May;108(5):936-44
pubmed: 11320025
World Allergy Organ J. 2017 Apr 18;10(1):14
pubmed: 28451053
Ophthalmology. 1999 Feb;106(2):362-9
pubmed: 9951491
Ann Allergy Asthma Immunol. 2005 Oct;95(4):361-71
pubmed: 16279567
Otolaryngol Head Neck Surg. 2004 Feb;130(2):187-91
pubmed: 14990914
J Allergy Clin Immunol. 2011 Dec;128(6):1139-1150.e4
pubmed: 22035879
Clin Ther. 2003 Mar;25(3):931-47
pubmed: 12852709
Clin Ther. 2005 Sep;27(9):1392-402
pubmed: 16291412